This study demonstrated that KLHL38 localizes in the cytoplasm and nucleus, and that its expression level correlates with a range of clinicopathological parameters in NSCLC, including tumor size, lymph node metastasis, and pathological tumor-node-metastasis stage. Here, KLHL38 is linked to non-small cell lung carcinoma.